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Abstract 
Background; A substantial proportion of children will experience at least one episode with bronchiolitis, and as 
much as 2-3% of all children will be hospitalized with bronchiolitis during their first year of life. Bronchiolitis is 
the most common reason for hospitalization of children in many countries, challenging both economy, area and 
staffing in paediatric departments. Objective; To compare efficacy of N-acetylcysteine nebulization versus 
salbutamol nebulization in children with acute bronchiolitis. Material and Methods; The study cases were 
randomly divided into 2 groups by draws methods. Group A, each child was nebulized with 20 mg NAC in 3 ml 
of 0.9% of saline while group B was nebulized with 2.5 mg salbutamol in 3 ml of 0.9% saline solution. Patients 
of each group were nebulized three times a day (8 hours apart) for 5 days. These patients were closely monitored 
for the severity of the disease daily and clinical severity score was employed to record any improvement in both 
cases.  All the data was entered and analyzed using SPSS-18. Results; Of these 390 study cases, 228 (58.5%) 
were boys while 162 (41.5%) were girls. Mean age of our study cases was 7.92 ± 5.18 months . Most of the 
study cases i.e. 264 (67.7%) were from poor social background and mothers of most of these children were less 
educated as 85.6% of the mothers of these children were having their educational status equal/less than 
matriculation. Mean hospital stay in our study was 4.73 ± 0.829 days. Mean baseline clinical severity score was 
5.52 ± 813. Mean clinical severity score after therapy was 1.85 ± 0.812 (with minimum clinical severity score 
was 1 while maximum was score was 4). Clinical severity score in group A was 1.21 ± 0.405 while in group B 
was 2.49 ± 0.578 (p= 0.000). Conclusion; Our study results support the use N – acetylcysteine nebulization in 
children with acute bronchiolitis as compared with salbutamol nebulization. N – acetylcysteine nebulization was 
found to be more effective in improving clinical severity score and reducing duration of hospitalization. Its use 
was safe, reliable and no adverse side effects were noted.  
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Introduction; 
Bronchiolitis is an acute inflammatory obstruction of small airways (bronchioles and alveoli) in 
children that occurs in first two years of life 1. It is characterized by fever, rhinitis, cough, tachypnea, expiratory 
wheeze and increased respiratory effort. Acute viral bronchiolitis is one of the most common causes of 
hospitalization during infancy with respiratory syncytial virus (RSV) being the major causative agent (85%) 2-4. 
Globally, among healthy, full term infants, 80% of hospitalizations occur in the first year of life and 
50% of hospitalizations occur in children 1-3 months of age. In Pakistan, acute respiratory illness (ARI) is the 
leading cause of death in young children responsible for 20-30% of all child death under age 5 years. It occurs in 
a seasonal pattern, with peak incidence in the winter to spring months. Risk factors for early onset disease and 
subsequent hospitalization include low birth weight, prematurity, lower socioeconomic group, crowded living 
conditions, parental smoking, absence of breast-feeding, and day care centers. Majority of the children present 
with respiratory distress and wheezing5-7. Pathophysiologically bronchiolitis is an infection of the bronchiolar 
epithelium with subsequent profound submucosal and advential oedema, increased secretion of mucus, 
peribronchiolar mononuclear infiltration and epithelial cell necrosis 8-10. These changes obstruct flow in the small 
airways leading to hyperinflation, atelectasis and wheezing8.  N-acetylcysteine (NAC) is an antioxidant that 
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cleaves disulphide bonds by converting them to 2 sulphuryl groups 11. This action results in the breakup of 
mucoproteins in lung mucus, reducing chain lengths and thinning mucus, mucolytics like NAC has been studies 
in the treatment of various diseases states such as pulmonary in nature ( cystic fibrosis, chronic bronchitis, 
idiopathic pulmonary fibrosis and critically ill states)9,12-15.  
A study has reported significant decrease in clinical severity score by using NAC nebulization versus 
salbutamol i.e. it was decreased from 5.38 ± 2.62 to 0.88 ± 1.08 with NAC and from 4.68 ± 2.2 to 1.90 ± 1.32 
after completion the course of therapy for 5 days6. Similarly mean duration for hospitalization was also short 
with NAC nebulization i.e. 4.36 ± 1.66 days versus 4.98 ± 2.6 days in case of salbutamol nebulization6. 
This study was done to determine outcome of NAC compared with those of salbutamol in the patients 
of acute bronchiolitis as there is very much limited data available of this topic.   
Patients and Methods; 
Three hundred and ninety hospitalized children with acute bronchiolitis were registered in this randomized 
controlled trial from Department of Pediatrics, Nishtar Hospital Multan. Patients with underlying broncho-
pulmonary dysplasia, chronic lung diseases, neuromuscular impairment, immunodeficiency or congenital heart 
disease, patients with previous history of malignancy and those already taking NAC or salbutamol therapy were 
excluded from our study. Informed consent was taken from the parents of each child, baseline information like 
heart rate, respiratory rate, wheeze score and clinical severity score were taken. Acute Bronchiolitis was defined 
as Children having clinical severity score more than 4 with fever (more than 101 F0) and cough within 2 days. 
These study cases were randomly divided into 2 groups by draws methods (Group A and Group B with 190 
patients in each group). Group A, each child was nebulized with 20 mg NAC in 3 ml of 0.9% of saline while 
group B was nebulized with 2.5 mg salbutamol in 3 ml of 0.9% saline solution. Patients of each group were 
nebulized three times a day (8 hours apart) for 5 days. These patients were closely monitored for the severity of 
the disease daily and clinical severity score was employed to record any improvement in both cases. Final 
outcome was measured at day five.  All the data was entered and analyzed using SPSS-18. Descriptive statistics 
was applied to calculate mean and standard deviation for age of patients, clinical severity score and duration of 
hospital stays. Frequencies and percentage was tabulated for the categorical variables like gender and age 
groups. Student’s t test was applied to compare clinical severity and hospital stay in both groups.  
Results; 
Our study included a total 390 children with acute bronchiolitis who met inclusion criteria of our study. 
Of these 390 study cases, 228 (58.5%) were boys while 162 (41.5%) were girls.  Mean age of our study cases 
was 7.92 ± 5.18 months ranging from 2 months to 24 months. Mean age of our study cases in group A was 8.07 
± 5.46 months while that of group B was 7.77 ± 4.91 months (p = 0.579) while 318 (81.5%) were aged less than 
12 months. Most of the study cases i.e. 264 (67.7%) were from poor social background and mothers of most of 
these children were less educated as 85.6% of the mothers of these children were having their educational status 
equal/less than matriculation. Mean hospital stay in our study was 4.73 ± 0.829 days ranging from 3 days to 7 
days). Mean baseline clinical severity score was 5.52 ± 813 (with minimum baseline clinical severity score was 5 
and maximum was 8). Mean clinical severity score after therapy was 1.85 ± 0.812 (with minimum clinical 
severity score was 1 while maximum was score was 4). Clinical severity score in group A was 1.21 ± 0.405 
while in group B was 2.49 ± 0.578 (p= 0.000).   
Discussion;  
Our study included a total 390 children with acute bronchiolitis who met inclusion criteria of our study. 
Of these 390 study cases, 228 (58.5%) were boys while 162 (41.5%) were girls. Different studies have 
documented male gender predominance in patients with acute bronchiolitis. A study conducted by Arif et al 16 
from Lahore reported 68 % boys with acute bronchiolitis which is similar to our study results. Another study 
from Faisalabad by Ahmed et al 17 reported 1.4:1 male to female ratio which is showing male gender 
predominance. Jacobs et al 18 reported 69 % boys with acute bronchiolitis showing male gender predominance. 
However Naz et al 6 from Lahore reported 40 % boys with acute bronchiolitis and 60 % girls which is quite 
different from our study results. Mean age of our study cases was 7.92 ± 5.18 months ranging from 2 months to 
24 months. Mean age of our study cases in group A was 8.07 ± 5.46 months while that of group B was 7.77 ± 
4.91 months (p = 0.579). Our study results have indicated that majority of our study cases i.e. 318 (81.5%) were 
aged less than 12 months. Airf et al 16 from Lahore reported 5.43 ± 9.44 months mean age of the children with 
acute bronchiolitis which is close to our study results. Ahmed et al 17 from Faisalabad reported 7.6 ± 4.7 months 
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mean age which is close to our study results. Jacobs et al 18 reported 6.0 ± 3.9 months mean age, similar to our 
results. Naz et al 6 reported 3 months mean age which is a bit lower than that of our study results. Most of the 
study cases i.e. 264 (67.7%) were from poor social background and mothers of most of these children were less 
educated as 85.6% of the mothers of these children were having their educational status equal/less than 
matriculation. Similar findings have been reported by Ahmed et al 17 from Faisalabad. Mean hospital stay in our 
study was 4.73 ± 0.829 days (with minimum hospital stay was 3 days while maximum hospital stay was 7 days). 
Flores et al 19 reported 5.4 ± 2.1 days hospital stay with acute bronchiolitis which is close to our study findings. 
Naz et al 6 reported 4.67 ± 2.2 days mean duration of hospitalization which is same as that of our study results. 
Mean baseline clinical severity score was 5.52 ± 813 (with minimum baseline clinical severity score was 5 and 
maximum was 8). A study conducted in Lahore by Ejaz et al 20 reported 5.68 ± 0.73 clinical severity score which 
is in compliance with our study results. Jacobs et al 18 reported 5.7 ± 1.8 mean score which is similar to that of 
our study results. Mean clinical severity score after therapy was 1.85 ± 0.812 (with minimum clinical severity 
score was 1 while maximum was score was 4). Clinical severity score in group A was 1.21 ± 0.405 while in 
group B was 2.49 ± 0.578 (p= 0.000). Naz et al 6 also reported similar results as mean score in group A (treated 
with N – acetylcystein) was 0.88 ± 1.08 while in group B treated with salbutamol was 1.90 ± 1.32. These results 
are same as that of our findings showing N – acetylcystein to be more effective.  
Conclusion; 
Our study results support the use N – acetylcysteine nebulization in children with acute bronchiolitis as 
compared with salbutamol nebulization. N – acetylcysteine nebulization was found to be more effective in 
improving clinical severity score and reducing duration of hospitalization significantly. Its use was safe, reliable 
and no adverse side effects were noted.  
  
References; 
1. Uyar M, Kuyucu N, Tezcan S, Aslan G, Tasdelen B. Determination of the frequency of human 
bocavirus and other respiratory viruses among 0-2 years age group children diagnosed as acute 
bronchiolitis. Mikrobiyol Bul. 2014;48(2):242-58. 
2. Frey U, von Mutius E. The challenge of managing wheezing in infants. N Engl J Med. 2009;360:2130-3. 
3. Calvo C, Pozo F, García-García ML, Sanchez M, Lopez-Valero M, Pérez-Breña P, et al . Detection of 
new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta 
Paediatr. 2010;99(6):883-7. 
4. Mansbach JM, Piedra PA, Teach SJ, Sullivan AF, Forgey T, Clark S, et al. Prospective multicenter 
study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr 
Adolesc Med. 2012;166(8):700-6. 
5. Iqbal SMJ, Afzal MF, Sultana MA. Acute bronchiolitis; epidemiological and clinical study. Ann. 
2009;15(4):203-5. 
6. Naz F, Raza AB, Ijaz I, Kazi MY. Effectiveness of nebulized N-acetylcysteine solution in children with 
acute bronchiolitis. J Coll Physicians Surg Pak. 2014;24(6):408-11. 
7. Ansari K, Sakran M, Davidson BL, Sayyed RE, Mahjoub H, Ibrahim K. Nebulized 5 % or 3% 
hypertonic or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr. 2010;157:630-4. 
8. Burgel R, Bergeron A, Blic JD, Bonniaud P, Bourdin A, Chanez P, et al. Small airways diseases, 
excluding asthma and COPD: an overview. Eur Respir Rev 2013;22:131–47. 
9. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Eng J Med. 2010;363:2233-44. 
10.  Kim IK1, Phrampus E, Sikes K, Pendleton J, Saville A, Corcoran T, et al. Helium-oxygen therapy for 
infants with bronchiolitis: a randomized controlled trial. Arch Pediatr Adolesc Med 2011;165:1115-22. 
11. Everard ML1, Hind D2, Ugonna K3, Freeman J4, Bradburn M2, Dixon S2, et al.  Saline in acute 
bronchiolitis RCT and economic evaluation: hypertonic saline in acute bronchiolitis - randomised 
controlled trial and systematic review. Health Technol Assess. 2015 Aug;19(66):1-130.  
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal DOI: 10.7176/JMPB 
Vol.55, 2019 
 
48 
12. Roqué i Figuls M1, Giné-Garriga M, Granados Rugeles C, Perrotta C, Vilaró J. Chest physiotherapy for 
acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 
2016 Feb 1;2:CD004873.  
13. Jat KR, Chawla D. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst 
Rev 2012;9:CD009194. 
14. Stockman LJ, Curns AT, Anderson LJ, Fischer-Langley G. Respiratory syncytial virus-associated 
hospitalizations among infants and young children in the United States, 1997–2006. Pediatr Infect Dis J. 
2012;31:5–9 
15. Øymar K1, Skjerven HO, Mikalsen IB. Acute bronchiolitis in infants, a review. Scand J Trauma Resusc 
Emerg Med. 2014 Apr 3;22:23. doi: 10.1186/1757-7241-22-23. 
16. Arif A, Tajammul A. Acute Bronchiolitis - a clinical study Pak Paed J. 1998;22(4):175-7.  
17. Ahmad S, Aamir S, Ahmad S. Acute bronchiolitis in children; epidemiologic and clinical features. 
Professional Med J. 2013;20(5):707-12.  
18. Jacobs JD1, Foster M, Wan J, Pershad J. 7% Hypertonic saline in acute bronchiolitis: a randomized 
controlled trial. Pediatrics. 2014 Jan;133(1):e8-13.  
19. Flores P1, Mendes AL1, Neto AS1. A randomized trial of nebulized 3% hypertonic saline with 
salbutamol in the treatment of acute bronchiolitis in hospitalized infants. Pediatr Pulmonol. 2016 
Apr;51(4):418-25.  
20. Ejaz I, Siddique A, Rathore AW, Khan HI. Hypertonic Saline (3%) vs Normal Saline (0.9%) 
Nebuliztion for Acute Viral Bronchiolitis: A Randomized Control Trial. Pak Paed J. 2015;39(4):248-51. 
 
